Xencor, Inc. (XNCR) Social Stream



Xencor, Inc. (XNCR): $27.37

0.17 (+0.63%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add XNCR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 397

in industry

Xencor Inc (XNCR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering XNCR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 6 $71 $49 $57.166 $27.48 108.03%
2021-11-12 6 $71 $49 $57.833 $27.48 110.45%
2021-12-12 6 $71 $49 $58 $27.48 111.06%
2022-01-02 7 $71 $49 $58.428 $27.48 112.62%
2022-02-08 8 $71 $49 $58.625 $27.48 113.34%
2022-02-14 9 $71 $49 $58.111 $27.48 111.47%
2022-03-22 9 $71 $49 $57.666 $27.48 109.85%

The Trend in the Analyst Price Target


Over the past 44 weeks, XNCR's average price target has gone up $3.67.

Over the past 50 weeks, XNCR's average upside potential has been 58.56%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-21 12 63 34 54.000 37.20 45.16%
2021-09-04 12 63 34 53.550 33.82 58.34%
2021-09-15 12 63 34 53.550 33.36 60.52%
2021-11-22 6 71 49 58.000 37.29 55.54%
2022-02-24 9 71 49 57.666 32.49 77.49%

XNCR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.11 8 1 0 0 0 9

The Trend in the Broker Recommendations


XNCR's average broker recommendation rating improved by 0.39 over the prior 16 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for XNCR as an investment opportunity.

  • In terms of how Xencor Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 555.56% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Xencor Inc's average analyst price target is greater than 517.6% of them.
  • In the context of Pharmaceutical Products stocks, Xencor Inc's variance in analysts' estimates is lower than -117.29% of them.
  • XNCR has a higher number of analysts covering the stock than 365.71% of stocks in the mid market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Xencor Inc are VERV, VALN, and UTHR.

Is XNCR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.757 seconds.